| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 10, 2025 | Kura Oncology, Inc. | Director | Sell | 10.0 | -10,000 | -29.43% | ✓ | $109.8K |
| Mar 21, 2025 | Mar 24, 2025 | Kura Oncology, Inc. | Director | Sell | 10.0 | -22,682 | -48.61% | ✓ | $181.5K |
| Jun 21, 2024 | Jun 24, 2024 | Gossamer Bio, Inc. | CEO | Buy | 92.5 | +372,000 | 7.21% | ✗ | $250.3K |
| Mar 27, 2024 | Mar 28, 2024 | Gossamer Bio, Inc. | CEO | Sell | 51.3 | -23,172 | -0.45% | ✗ | $26.8K |
| Mar 20, 2023 | Mar 22, 2023 | Gossamer Bio, Inc. | CEO | Buy | 100.0 | +878,572 | 23.36% | ✗ | $1M |
| Jul 15, 2022 | Jul 15, 2022 | Gossamer Bio, Inc. | CEO | Buy | 90.0 | +138,696 | 3.83% | ✗ | $1000K |
| Mar 23, 2022 | Mar 24, 2022 | Gossamer Bio, Inc. | CEO | Sell | 45.0 | -19,035 | -0.52% | ✗ | $169.7K |
| Oct 14, 2020 | Oct 14, 2020 | Gossamer Bio, Inc. | Director | Buy | 90.0 | +96,520 | 2.85% | ✗ | $1000K |
| Sep 27, 2019 | Sep 27, 2019 | Gossamer Bio, Inc. | Director | Buy | 65.0 | +10,000 | 0.30% | ✗ | $168K |
| May 30, 2019 | Jun 3, 2019 | Forte Biosciences, Inc. | Director | Buy | 95.0 | +43,000 | 21.20% | ✗ | $200.3K |
| Sep 13, 2018 | Sep 17, 2018 | IMMUNIC, INC. | Director | Sell | 22.5 | -177,443 | -95.69% | ✗ | $77.7K |
| Sep 14, 2017 | Sep 15, 2017 | IMMUNIC, INC. | Director | Buy | 95.0 | +59,200 | 46.89% | ✗ | $247.9K |
| Apr 19, 2017 | Apr 21, 2017 | Forte Biosciences, Inc. | Director | Buy | 100.0 | +202,857 | 100.00% | ✗ | $2M |
| Aug 12, 2016 | Aug 15, 2016 | IMMUNIC, INC. | Director | Buy | 97.5 | +118,243 | 1478.04% | ✗ | $700K |